Annual Drug Patent Expirations for GOCOVRI
Gocovri is a drug marketed by Adamas Pharma and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for GOCOVRI.
This drug has twenty-three patent family members in seven countries.
The generic ingredient in GOCOVRI is amantadine hydrochloride. One supplier is listed for this compound. Additional details are available on the amantadine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
